Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Solesence (SLSN) Cash & Equivalents (2016 - 2025)

Solesence's Cash & Equivalents history spans 16 years, with the latest figure at $1.3 million for Q4 2025.

  • For Q4 2025, Cash & Equivalents fell 8.59% year-over-year to $1.3 million; the TTM value through Dec 2025 reached $1.3 million, down 8.59%, while the annual FY2025 figure was $1.3 million, 8.59% down from the prior year.
  • Cash & Equivalents reached $1.3 million in Q4 2025 per SLSN's latest filing, up from $429000.0 in the prior quarter.
  • In the past five years, Cash & Equivalents ranged from a high of $4.1 million in Q2 2025 to a low of $429000.0 in Q3 2025.
  • Average Cash & Equivalents over 5 years is $1.6 million, with a median of $1.4 million recorded in 2021.
  • Peak YoY movement for Cash & Equivalents: skyrocketed 232.72% in 2022, then tumbled 85.33% in 2025.
  • A 5-year view of Cash & Equivalents shows it stood at $657000.0 in 2021, then surged by 232.72% to $2.2 million in 2022, then dropped by 21.23% to $1.7 million in 2023, then fell by 18.18% to $1.4 million in 2024, then dropped by 8.59% to $1.3 million in 2025.
  • Per Business Quant, the three most recent readings for SLSN's Cash & Equivalents are $1.3 million (Q4 2025), $429000.0 (Q3 2025), and $4.1 million (Q2 2025).